Now showing items 1-5 of 5
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| Can Zika virus antibodies cross-protect against dengue virus? [letter] | Ariën, K. K.; Michiels, J.; Foque, N.; Heyndrickx, L.; Van Esbroeck, M. | Lancet Global Health | 2018 | Letter-E |
| Dengue vaccine: reliably determining previous exposure [comment] | Ariën, K. K.; Wilder-Smith, A. | Lancet Global Health | 2018 | Comment-E |
| Effectiveness of a community-based educational programme in reducing the cumulative incidence and prevalence of human Taenia solium cysticercosis in Burkina Faso in 2011-14 (EFECAB): a cluster-randomised controlled trial | Carabin, H.; Millogo, A.; Ngowi, H. A.; Bauer, C.; Dermauw, V.; Kone, A. C.; Sahlu, I.; Salvator, A. L.; Preux, P. M.; Some, T.; Tarnagda, Z.; Gabriel, S.; Cisse, R.; Ouedraogo, J. B.; Cowan, L. D.; Boncoeur-Martel, M. P.; Dorny, P.; Ganaba, R. | Lancet Global Health | 2018 | Article-E |
| Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial | Mavoko, H. M.; Nabasumba, C.; da Luz, R. I.; Tinto, H.; D'Alessandro, U.; Kambugu, A.; Baraka, V.; Rosanas-Urgell, A.; Lutumba, P.; Van geertruyden, J. P. | Lancet Global Health | 2017 | Article-E |
| Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study | Büscher, P.; Mertens, P.; Leclipteux, T.; Gilleman, Q.; Jacquet, D.; Mumba-Ngoyi, D.; Pyana, P. P.; Boelaert, M.; Lejon, V. | Lancet Global Health | 2014 | Article-E |
Now showing items 1-5 of 5